🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Vaqta™

Found 59 matching trials

Long-Term Study on Safety and Immunogenicity of HEPLISAV™ and Engerix-B® in Adults With Chronic Kidney Disease

N/A

The purpose of this study is to determine the durability of seroprotection ...

Status

Completed

Location

Clinical Research Associates of Tidewater

Start Date

2010-12

Trial ID

NCT01282762

Treatments Being Tested

HEPLISAV Engerix-B

Evaluation of Immune Memory to Twinrix or Comparator by Challenge Dose Administration 4 Years After Primary Vaccination

PHASE4

Only subjects who participated in the primary study will be invited to part...

Status

Completed

Location

GSK Investigational Site

Start Date

2008-05-26

Trial ID

NCT00684671

Treatments Being Tested

Twinrix Engerix-B Havrix HBVAXPRO Vaqta

Immune Response to Hepatitis B Vaccine Challenge Dose in Subjects Who Received a Primary Neonatal Hepatitis B Vaccine.

PHASE4

The current study will evaluate immunological memory to hepatitis B antigen...

Status

Completed

Location

GSK Investigational Site

Start Date

2007-04

Trial ID

NCT00456625

Treatments Being Tested

Engerix™-B

Immunogenicity of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® at 2-3-4 Months Schedule

PHASE3

To demonstrate that the immune response to hepatitis B antigen of the DTaP-...

Status

Completed

Location

Multiple Locations

Start Date

2006-07

Trial ID

NCT00315055

Treatments Being Tested

DTaP-IPV-HB-PRP~T vaccine DTaP-IPV//PRP~T combined Hepatitis B vaccine

Immunogenicity and Safety of Havrix™ Co-Administered With a Diphtheria, Tetanus and Pertussis and a Haemophilus b Vaccine in Children Aged 15 Months

PHASE3

This is a study to evaluate the immune response and safety of GSK Biologica...

Status

Completed

Location

GSK Investigational Site

Start Date

2003-11-11

Trial ID

NCT00197236

Treatments Being Tested

Havrix™Infanrix™ActHIB™

Immunogenicity and Safety of ChimeriVax™ Japanese Encephalitis Vaccine in Thai Toddlers and Children

PHASE2

Safety: To describe the safety profiles following vaccination. Immunogeni...

Status

Completed

Location

Multiple Locations

Start Date

2008-03

Trial ID

NCT00621764

Treatments Being Tested

Japanese encephalitis vaccine (Day 0) Hepatitis A vaccine (Day 28)Hepatitis A vaccine (Day 0) Japanese encephalitis vaccine (Day 28)Japanese encephalitis vaccine (Day 0) Hepatitis A vaccine (Day 28)Hepatitis A vaccine (Day 0) Japanese encephalitis vaccine (Day 28)

Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Pneumococcal Vaccine in Healthy Children 15 m of Age

PHASE3

This is a study to evaluate the immunogenicity and safety of GSK Biological...

Status

Completed

Location

GSK Investigational Site

Start Date

2003-09-11

Trial ID

NCT00197002

Treatments Being Tested

GSK Biologicals 2-dose inactivated hepatitis A vaccine (Havrix)Prevnar™

Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18

PHASE3

Human Papilloma virus (HPV) are viruses that cause a common infection of th...

Status

Completed

Location

GSK Investigational Site

Start Date

2004-05-06

Trial ID

NCT00122681

Treatments Being Tested

Cervarix™Havrix™-based investigational formulation

Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine

PHASE3

This protocol posting deals with objectives \& outcome measures of the exte...

Status

Completed

Location

GSK Investigational Site

Start Date

2005-10

Trial ID

NCT00316706

Treatments Being Tested

GSK Biologicals' HPV-16/18 Vaccine (Cervarix™)Havrix™

Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Month Schedule

PHASE3

The aim of this study is to evaluate the long-term persistence of hepatitis...

Status

Completed

Location

GSK Investigational Site

Start Date

2004-11-01

Trial ID

NCT00289718

Treatments Being Tested

Twinrix™ adult

Previous Next